张津,龚艳君,郑博

• 1:北京大学第一医院心内科心血管疾病研究所

摘要(Abstract)：

冠状动脉微血管功能障碍会导致不良心血管事件风险增加，准确识别冠状动脉微血管功能障碍对疾病干预和预后意义重大。随着有创和无创技术的发展，出现多种方法评估冠状动脉微循环，如核素显像、磁共振成像以及有创的冠状动脉微循环阻力指数，其中基于冠状动脉造影的微循环阻力指数受到了更多的关注。本文将对各种冠状动脉微循环评估方法的原理、准确性、预后研究、优势和局限性进行综述。

关键词(KeyWords)： 冠状动脉微循环;功能学评估;基于冠状动脉造影的微循环阻力指数

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目（2021YFA1000204,2021YFA1000200）;; 中央高水平医院临床科研业务费资助项目（北京大学第一医院跨学科交叉研究专项）（2022CR03）;; 中国国际医学交流基金会项目（2021-N-15-5）

作者(Author): 张津,龚艳君,郑博

参考文献(References)：

• [1]马丽媛，王增武，樊静，等.《中国心血管健康与疾病报告2021》概要[J].中国介入心脏病学杂志，2022,30(7):481-496. DOI:10. 3969/j. issn. 1004-8812. 2022. 07. 001.
• [2] Kunadian V, Chief fo A, Camici PG, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on coronary pathophysiologyµcirculation endorsed by Coronary Vasomotor Disorders International Study Group[J]. Eur Heart J, 2020,41(37):3504-3520. DOI:10.1093/eurheartj/ehaa503.
• [3] Gdowski MA,Murthy VL,Doering M,et al. Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events:a systematic review and metaanalysis of aggregate data[J]. J Am Heart Assoc, 2020, 9(9):e014954. DOI:10.1161/JAHA.119.014954.
• [4] Monroy-Gonzalez AG, Tio RA, de Groot JC, et al.Longterm prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteries[J]. J Nucl Cardiol,2019,26(6):1844-1852. DOI:10.1007/s12350-018-1448-8.
• [5] Beitzke D, Rasul S, Lassen ML, et al. Assessment of myocardial viability in ischemic heart disease by PET/MRI:comparison of left ventricular perfusion, hibernation, and scar burden[J]. Acad Radiol,2020,27(2):188-197. DOI:10.1016/j.acra.2019.03.021.
• [6] Ong P, Safdar B, Seitz A, et al. Diagnosis of coronary microvascular dysfunction in the clinic[J]. Cardiovasc Res,2020,116(4):841-855. DOI:10.1093/cvr/cvz339.
• [7] Kotecha T, Martinez-Naharro A, Boldrini M, et al.Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction:validation against invasive coronary physiology[J]. JACC Cardiovasc Imaging, 2019,12(10):1958-1969. DOI:10.1016/j.jcmg.2018.12.022.
• [8] Zhou W, Lee JCY, Leung ST, et al. Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance[J]. JACC Cardiovasc Imaging,2021,14(3):602-611. DOI:10.1016/j.jcmg.2020.09.034.
• [9] Cin VG, Pekdemir H, Camsar A, et al. Diffuse intimal thickening of coronary arteries in slow coronary fl ow[J]. Jpn Heart J, 2003,44(6):907-919. DOI:10.1536/jhj.44.907.
• [10] Everaars H, de Waard GA, Driessen RS,et al. Doppler fl ow velocity and thermodilution to assess coronary flow reserve:a head-to-head comparison with[15O]H2O PET[J]. JACC Cardiovasc Interv, 2018,11(20):2044-2054. DOI:10.1016/j.jcin.2018.07.011.
• [11] Kelshiker MA, Seligman H, Howard JP, et al. Coronary fl ow reserve and cardiovascular outcomes:a systematic review and Meta-analysis[J]. Eur Heart J,2022,43(16):1582-1593.DOI:10.1093/eurheartj/ehab775.
• [12] Lee JM, Choi KH, Hwang D, et al. Prognostic implication of thermodilution coronary flow reserve in patients undergoing fractional flow reserve measurement[J]. JACC Cardiovasc Interv,2018,11(15):1423-1433. DOI:10.1016/j.jcin.2018.05.005.
• [13]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.缺血伴非阻塞性冠状动脉疾病诊断及管理中国专家共识[J].中华心血管病杂志，2022, 50(12):1148-1160. DOI:10.3760/cma. j.cn112148-20220908-00682.
• [14] Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation[J]. Circulation, 2003,107(25):3129-3132. DOI:10.1161/01.CIR.0000080700.98607.D1.
• [15] Knuuti J, Wijns W, Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3):407-477. DOI:10.1093/eurheartj/ehz425.
• [16] Qi Y, Gu R, Xu J, et al. Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI[J]. BMC Cardiovasc Disord,2021,21(1):66. DOI:10.1186/s12872-021-01887-w.
• [17] De Maria GL, Scarsini R, Shanmuganathan M, et al. Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction[J]. Int J Cardiovasc Imaging, 2020, 36(8):1395-1406. DOI:10.1007/s10554-020-01831-7.
• [18] Huang D, Gong Y, Fan Y,et al. Coronary angiographyderived index for assessing microcirculatory resistance in patients with non-obstructed vessels:the FLASH IMR study[J]. Am Heart J, 2023,263:56-63. DOI:10.1016/j.ahj.2023.03.016.
• [19] Fan Y, Fezzi S, Sun P,et al. In vivo validation of a novel computational approach to assess microcirculatory resistance based on a single angiographic view[J]. J Pers Med, 2022,12(11):1798. DOI:10.3390/jpm12111798.
• [20] Jiang J, Li C, Hu Y,et al. A novel CFD-based computed index of microcirculatory resistance(IMR)derived from coronary angiography to assess coronary microcirculation[J]. Comput Methods Programs Biomed, 2022,221:106897. DOI:10.1016/j.cmpb.2022.106897.
• [21] Fan Y, Li C, Hu Y, et al. Angiography-based index of microcirculatory resistance(AccuIMR)for the assessment of microvascular dysfunction in acute coronary syndrome and chronic coronary syndrome[J]. Quant Imaging Med Surg,2023,13(6):3556-3568. DOI:10.21037/qims-22-961.
• [22] Li W, Takahashi T, Rios SA, et al. Diagnostic performance and prognostic impact of coronary angiography-based index of microcirculatory resistance assessment:a systematic review and meta-analysis[J]. Catheter Cardiovasc Interv, 2022,99(2):286-292. DOI:10.1002/ccd.30076.
• [23] Choi KH, Dai N, Li Y, et al. Functional coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction[J].JACC Cardiovasc Interv, 2021,14(15):1670-1684. DOI:10.1016/j.jcin.2021.05.027.
• [24] Hou C, Guo M, Ma Y,et al. The coronary angiographyderived index of microcirculatory resistance predicts left ventricular performance recovery in patients with ST-Segment elevation myocardial infarction[J]. J Interv Cardiol, 2022,2022:9794919. DOI:10.1155/2022/9794919.
• [25] Zhang W, Singh S, Liu L, et al. Prognostic value of coronary microvascular dysfunction assessed by coronary angiography-derived index of microcirculatory resistance in diabetic patients with chronic coronary syndrome[J].Cardiovasc Diabetol, 2022,21(1):222. DOI:10.1186/s12933-022-01653-y.
• [26] Abdu FA, Liu L, Mohammed AQ, et al. Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries[J]. Eur J Intern Med,2021,92:79-85. DOI:10.1016/j.ejim.2021.05.027.
• [27] Toya T, Ahmad A, Corban MT,et al. Risk stratification of patients with nonobstructive coronary artery disease using resistive reserve ratio[J]. J Am Heart Assoc, 2021,10(11),e020464. DOI:10.1161/JAHA.120.020464.
• [28] de Waard GA, Nijjer SS, van Lavieren MA, et al. Invasive minimal microvascular resistance is a new index to assess microcirculatory function independent of obstructive coronary artery disease[J]. J Am Heart Assoc, 2016,5(12):e004482. DOI:10.1161/JAHA.116.004482.
• [29] Zeng X, Holck EN, Westra J, et al. Impact of coronary plaque morphology on the precision of computational fractional flow reserve derived from optical coherence tomography imaging[J].Cardiovasc Diagn Ther, 2022,12(2):155-165. DOI:10.21037/cdt-21-505.
• [30] Mailey JA, Moore JS, Brennan PF,et al. Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction[J]. Microvasc Res, 2023, 147:104480. DOI:10.1016/j.mvr.2023.104480.